C
CRBU
Caribou Biosciences, Inc.
1.540
-0.030-1.91%After Hours: 1.580 +0.040 +2.60%19:30 09/08 EDT
OPEN/PREV CLOSE1.570/1.570
TODAY RANGE1.540-1.580
VOL717.63K
MARKET CAP165.10M
52 WEEK RANGE1.380-3.535
AVG VOL (3M)1.68M
% TURNOVER0.64%
TURNOVER--
P/E (TTM)-1.4290
% RANGE2.55%
EPS(TTM)-1.0777
P/E(FORWARD)-1.4380
P/B1.664
BVPS0.9255
DIVIDEND--
P/S13.13
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP151.53M
SHARES OUTSTANDING107.21M
NEXT EARNINGS11/09-11/22
FREE FLOAT98.40M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·08/26 15:17
Here's Why You Should Retain IQVIA Stock in Your Portfolio Now
TipRanks·08/17 10:29
RBC Capital Keeps Their Buy Rating on Caribou Biosciences (CRBU)
TipRanks·08/16 14:03
Caribou Biosciences reports Q2 EPS (24c), consensus (31c)
TipRanks·08/16 13:45
Caribou Biosciences price target lowered to $5 from $6 at BofA
Dow Jones·08/14 18:35
Caribou Biosciences Price Target Cut to $5.00/Share From $6.00 by B of A Securities
Dow Jones·08/14 18:35
Caribou Biosciences Is Maintained at Buy by B of A Securities
Seeking Alpha·08/14 17:18
Adicet Bio: A Cheap Gamma Delta T-Cell Play
NASDAQ·08/13 22:05
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Lags Revenue Estimates
Dow Jones·08/13 20:05
Press Release: Caribou Biosciences Reports Second -2-
Simply Wall St·08/06 17:05
Spotlight On Promising Penny Stocks For August 2026
TipRanks·07/06 18:35
Citizens biotech analyst holds an analyst/industry conference call
TipRanks·07/02 19:25
Citizens biotech analysts hold an analyst/industry conference call
Same Industry
Name/Symbol
Change%
Price